The pharmaceutical industry’s relentless, astronomically expensive campaign to smear the 340B Drug Pricing Program — one of the world’s most important humanitarian programs — knows no bounds. Our healthcare safety net is under attack.

Recommended Stories

Federal judge blocks Trump rule cutting drug payments to hospitals

Hospitals lose bid to roll back cuts to drug discount program

340B drug program was created to help patients, not boost hospital profits